Hogenhuis Wladimir 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Oct 9, 2018
Insider Transaction Report
Form 4
Hogenhuis Wladimir
Chief Operating Officer
Transactions
- Award
Common Stock
2018-10-04+15,000→ 15,000 total - Award
Stock Option (Right to Buy)
2018-10-04+75,000→ 75,000 totalExercise: $77.30Exp: 2028-10-04→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
- [F2]On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.